Edwards Lifesciences Total Assets 2010-2024 | EW

Edwards Lifesciences total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Edwards Lifesciences total assets for the quarter ending September 30, 2024 were $12.971B, a 38.42% increase year-over-year.
  • Edwards Lifesciences total assets for 2023 were $9.363B, a 12.91% increase from 2022.
  • Edwards Lifesciences total assets for 2022 were $8.293B, a 2.47% decline from 2021.
  • Edwards Lifesciences total assets for 2021 were $8.503B, a 17.49% increase from 2020.
Edwards Lifesciences Annual Total Assets
(Millions of US $)
2023 $9,363
2022 $8,293
2021 $8,503
2020 $7,237
2019 $6,488
2018 $5,324
2017 $5,666
2016 $4,510
2015 $4,056
2014 $3,523
2013 $2,710
2012 $2,222
2011 $1,981
2010 $1,767
2009 $1,616
Edwards Lifesciences Quarterly Total Assets
(Millions of US $)
2024-09-30 $12,971
2024-06-30 $10,099
2024-03-31 $9,736
2023-12-31 $9,363
2023-09-30 $9,371
2023-06-30 $9,004
2023-03-31 $8,651
2022-12-31 $8,293
2022-09-30 $8,638
2022-06-30 $8,425
2022-03-31 $8,420
2021-12-31 $8,503
2021-09-30 $8,160
2021-06-30 $7,662
2021-03-31 $7,214
2020-12-31 $7,237
2020-09-30 $6,801
2020-06-30 $6,424
2020-03-31 $6,076
2019-12-31 $6,488
2019-09-30 $5,966
2019-06-30 $5,574
2019-03-31 $5,469
2018-12-31 $5,324
2018-09-30 $5,958
2018-06-30 $5,686
2018-03-31 $5,825
2017-12-31 $5,666
2017-09-30 $5,488
2017-06-30 $5,139
2017-03-31 $4,780
2016-12-31 $4,510
2016-09-30 $4,339
2016-06-30 $4,051
2016-03-31 $3,854
2015-12-31 $4,056
2015-09-30 $3,877
2015-06-30 $3,608
2015-03-31 $3,488
2014-12-31 $3,523
2014-09-30 $3,350
2014-06-30 $3,327
2014-03-31 $2,652
2013-12-31 $2,710
2013-09-30 $2,531
2013-06-30 $2,340
2013-03-31 $2,297
2012-12-31 $2,222
2012-09-30 $2,196
2012-06-30 $2,075
2012-03-31 $2,004
2011-12-31 $1,981
2011-09-30 $1,983
2011-06-30 $2,002
2011-03-31 $1,931
2010-12-31 $1,767
2010-09-30 $1,725
2010-06-30 $1,642
2010-03-31 $1,604
2009-12-31 $1,616
2009-09-30 $1,602
2009-06-30 $1,465
2009-03-31 $1,359
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.062B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $211.041B 25.75
Intuitive Surgical (ISRG) United States $191.072B 99.90
Alcon (ALC) Switzerland $45.679B 32.16
IQVIA Holdings (IQV) United States $39.790B 21.92
IDEXX Laboratories (IDXX) United States $35.479B 41.78
DexCom (DXCM) United States $27.326B 41.15
Waters (WAT) United States $22.831B 33.76
SONOVA HOLDING (SONVY) Switzerland $22.110B 0.00
STERIS (STE) Ireland $21.616B 24.91
Hologic (HOLX) United States $18.294B 19.30
Sysmex ADR (SSMXY) Japan $12.864B 40.34
Fresenius Medical Care AG KGaA (FMS) Germany $12.499B 12.83
Globus Medical (GMED) United States $10.952B 27.89
Teleflex (TFX) United States $9.082B 14.49
Penumbra (PEN) United States $9.075B 88.89
Masimo (MASI) United States $8.696B 42.08
Glaukos (GKOS) United States $7.816B 0.00
PROCEPT BioRobotics (PRCT) United States $5.170B 0.00
Integer Holdings (ITGR) United States $4.587B 26.00
Inari Medical (NARI) United States $3.009B 0.00
TransMedics (TMDX) United States $2.886B 91.47
LivaNova (LIVN) United Kingdom $2.804B 16.18
Veracyte (VCYT) United States $2.802B 84.84
Nihon Kohden (NHNKY) Japan $2.648B 20.12
Elekta AB (EKTAY) Sweden $2.286B 18.62
Tandem Diabetes Care (TNDM) United States $2.010B 0.00
Integra LifeSciences Holdings (IART) United States $1.912B 9.99
RxSight (RXST) United States $1.776B 0.00
Alphatec Holdings (ATEC) United States $1.333B 0.00
Pulse Biosciences (PLSE) United States $1.222B 0.00
Artivion (AORT) United States $1.203B 79.75
OPKO Health (OPK) United States $1.060B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.938B 15.95
ORTHOFIX MEDICAL INC (OFIX) United States $0.741B 0.00
IRadimed (IRMD) United States $0.716B 38.68
Mesa Laboratories (MLAB) United States $0.643B 15.22
SiBone (SIBN) United States $0.639B 0.00
Pacific Biosciences Of California (PACB) United States $0.627B 0.00
OrthoPediatrics (KIDS) United States $0.623B 0.00
Paragon 28 (FNA) United States $0.597B 0.00
AxoGen (AXGN) United States $0.555B 0.00
Treace Medical Concepts (TMCI) United States $0.501B 0.00
CVRx (CVRX) United States $0.377B 0.00
Tactile Systems Technology (TCMD) United States $0.360B 19.51
ClearPoint Neuro (CLPT) United States $0.321B 0.00
Delcath Systems (DCTH) United States $0.307B 0.00
AngioDynamics (ANGO) United States $0.293B 0.00
Semler Scientific (SMLR) United States $0.289B 19.43
Inogen (INGN) United States $0.263B 0.00
NeuroPace (NPCE) United States $0.219B 0.00
Accuray (ARAY) United States $0.216B 0.00
Sight Sciences (SGHT) United States $0.213B 0.00
Nevro (NVRO) United States $0.189B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
Alpha Tau Medical (DRTS) Israel $0.158B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.124B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.111B 16.51
EDAP TMS S.A (EDAP) France $0.095B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.082B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
Hyperfine (HYPR) United States $0.069B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.056B 0.00
Rapid Micro Biosystems (RPID) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.050B 0.00
Accelerate Diagnostics (AXDX) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.041B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Adagio Medical Holdings (ADGM) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
NexGel (NXGL) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.006B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00